Sanofi announced its intention to separate its CHC unit last year through the creation ... Opella’s current portfolio of products includes brands such as Allegra, Doliprane and Dulcolax.

Image Source: Zacks Investment Research Sanofi announced its intention to separate its CHC unit last year through ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online meetings, calls, and ...

French drugmaker Sanofi's announcement that it will sell a controlling ... in France – would help build Opella into a "French-headquartered, global consumer health care champion," the pharma giant ...

Editorial Note: Blueprint may earn a commission from affiliate partner links featured here on our site. This commission does not influence our editors' opinions or evaluations. Please view our ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Sanofi gets rated buy today ... as it has been driving revenue from multiple products rather than a single magic drug.